Drug Safety Fears May Limit Reimporting and Shape R&D

February 2, 2005
Jill Wechsler
Pharmaceutical Technology

Volume 29, Issue 2

Concerns about risky medicines may reduce pressure to expand drug imports while boosting demand for more comparative analyses of therapies.